CC1 Flashcards

1
Q

Enumerate Prostate Enzymes

A

ACP
G-6-PDH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Enumerate Miscellaneous Enzymes

A

5’ nucleotidase
Cholinesterase/pseudocholinesterase
Angiotensin Converting Enzyme (ACE)
Ceruloplasmin
Ornithine Carbamoyl Transferase (OCT)
G-6-PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a phosphoric monoester hydrolase

A

5’ N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

5’ N source

A

predominantly secreted by the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Marker for hepatobiliary disease and infiltrative lesions of the liver

A

5’ N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

5’ N is a marker for these conditions

A

Hepatobiliary disease
Infiltrative lesions of the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

reference range for 5’N

A

0-1.6 units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

index of parenchymal function of the liver

A

Cholinesterase/
Pseudocholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholinesterase/Pseudocholinesterase source

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Monitor effects of muscle relaxants (succinylcholine) after surgery

A

Cholinesterase/
Pseudocholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Marker for insecticide/pesticide poisoning (organophosphate – poisonous agent)

A

Cholinesterase/
Pseudocholinesterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

reference range for cholinesterase/pseudocholinesterase

A

0.5-1.3 units (plasma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a.k.a Peptidyldipeptidase A or Kininase II

A

Angiotensin Converting Enzyme (ACE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

aka Angiotensin Converting Enzyme (ACE)

A

Peptidyldipeptidase A or Kininase II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Converts angiotensin I to angiotensin II within the lungs (RAAS)

A

ACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primary enzyme of RAAS

A

Angiotensin Converting Enzyme (ACE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Promotes vasoconstriction of the renal arterioles to increase blood pressure and stimulates the adrenal cortex to release aldosterone so that aldosterone will promote Na reabsorption

A

Angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Events that activates RAAS

A

Blood pressure/volume is decrease
Low plasma sodium level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

source of ACE

A

Macrophage and epithelioid cells of the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Possible indicator of neuronal dysfunction
(Alzheimer’s/neurodegenerative disease)

A

ACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ACE is increased in these conditions

A

Sarcoidosis
Acute and chronic bronchitis
Leprosy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Copper-carrying protein which acts as an enzyme

A

Ceruloplasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Marker for Wilson’s disease (hepatolenticular disease)

A

Ceruloplasmin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clin. significance of Ornithine Carbamoyl Transferase (OCT)

A

Hepatobiliary diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Reference range for Ornithine Carbamoyl Transferase (OCT)

A

8-20 mU/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Maintain NADPH in the reduced form in the RBCs

A

G-6-PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Specimen for G6PD

A

Red cell hemolysate
Serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Responsible for maintaining and stabilizing
the membrane integrity of RBCs

A

reduced NADH (maintained by G6PD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Protects RBCs from toxic agents that can
induce hemolytic reactions

A

Reduced NADH (maintained by G6PD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Sources of G6PD

A

• Adrenal cortex
• Spleen
• RBC
• Lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Enzyme used as a newborn screening marker

A

G6PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

G6PD is INCREASED in these conditions

A

MI
Megaloblastic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

G6PD is DECREASED in these conditions

A

Drug-induced hemolytic anemia (intake of primaquine, antimalarial drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Reference range for G6PD

A

10-15 U/g Hgb
1200-2000 mU/mL pRBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Biologic intracellular proteins that catalyze biochemical reactions

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Affects the reaction of the organic matter

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

NOT consumed/changed in composition (only substrate → product)

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Increased enzymes in serum is due to the following conditions

A

Cell injury/degradation

Increased membrane permeability

Organ damage (severely increased enzyme in serum/plasma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What happen when there is an increased membrane permeability?

A

INCREASED ENZYMES in serum, allowing these proteins to move out easily from the cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Enzymes are found in _____________

A

all body tissue (intracellular)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Concentration in serum is very low as it is very abundant in cytoplasm

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Indication when there is a SEVERELY INCREASED enzyme in serum/plasma

A

Organ damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

FUNCTION OF ENZYMES

A
  1. Hydration of Carbon Dioxide (respiration)
  2. Nerve Induction (fast nerve impulse transmission)
  3. Muscle Contraction (locomotion)
  4. Nutrient Degradation (digestion)
  5. Growth and Reproduction (work with hormones)
  6. Energy Storage and Use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Enzymes with similar catalytic activity, but differ in their physical, biochemical, and immunologic properties

A

Isoenzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What are the difference between enzymes and its isoenzymes?

A

physical, biochemical, and immunologic properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the similarity between enzymes and its isoenzymes?

A

catalytic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Type of cofactor that serve as a second substrate for enzyme

A

COENZYME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

coenzyme tightly bound to an enzyme

A

Prosthetic group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

T/F

If there is a coenzyme in the reaction, enzyme involved is oxidoreductase – ends with “dehydrogenase” (promotes redox reaction)

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Part of the reagent since the primary enzyme is the target in the serum

A

Secondary coupling/indicator enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Requires a coenzyme: pyridoxal phosphate/Vit B6

A

Aminotransferases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Coenzyme required by aminotransferases

A

pyridoxal phosphate/Vit B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

A cofactor that enhances enzyme activity by altering the spatial configuration of the active site of enzyme or
enhanced substrate finding

A

Activator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Types of cofactor

A

Coenzyme
Activator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

These can be grouped as metallic or nonmetallic

A

Activators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Metallic activators

A

Mg, Iron, Zinc, Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Nonmetallic activators

A

Cl, Br

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

when used as coenzyme, it is converted into two forms when acted upon by oxidoreductase

A

NAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Oxidized form acted upon by Oxidoreductase

A

NAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Reduced form acted upon by Oxidoreductase

A

NADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Measured absorbance if the product is OXIDIZED form

A

NAD
Measured: DECREASE in absorbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Measured absorbance if the product is REDUCED form

A

NADH
Measured: INCREASE (HIGH) in absorbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Enumerate liver enzymes

A

AST/SGOT
ALT/SGPT
GGT
ALP/Alkaline Orthophosphoric Monoester Phosphohydrolase
ACP/Acid Orthophosphoric Monoester Phosphohydrolase
5’ N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Enumerate cardiac enzymes

A

CK
LDH
AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Enumerate non-enzymatic cardiac markers

A

Myoglobin
Troponins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Enumerate pancreatic enzymes

A

AMS
LPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Type of enzyme:

Aspartate Aminotransferase (AST)/
Serum glutamic-oxaloacetic
transaminase (SGOT)

A

TRANSFERASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Type of enzyme:
Alanine Aminotransferase (ALT)/
Serum glutamic-pyruvic
transaminase (SGPT)

A

TRANSFERASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Type of enzyme:
Gamma-Glutamyltransferase
(GGT)

A

TRANSFERASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Type of enzyme:
Acid Phosphatase (ACP)/
Acid Orthophosphoric Monoester
Phosphohydrolase

A

HYDROLASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Type of enzyme:
Alkaline Phosphatase (ALP)/
Alkaline Orthophosphoric
Monoester Phosphohydrolase

A

HYDROLASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Type of enzyme:
CK/CKP

A

TRANSFERASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Type of enzyme:
LDH

A

OXIDOREDUCTASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Type of enzyme:
5’ nucleotidase (5’N)

A

phosphoric monoester HYDROLASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Type of enzyme:
Amylase (AMS)

A

HYDROLASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Type of enzyme:
Lipase (LPS)

A

HYDROLASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Transfer of an amino group between aspartate and α-keto glutaric acid

A

Aspartate Aminotransferase (AST)/
Serum glutamic-oxaloacetic transaminase (SGOT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Involved in the synthesis and degradation of
AA (protein catabolism, deamination)

A

Aspartate Aminotransferase (AST)/
Serum glutamic-oxaloacetic
transaminase (SGOT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Major organ affected of AST/SGOT

A

HEART

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Substrate for AST/SGOT

A

Aspartic acid (aspartate)

a-ketoglutaric acid (a-ketoglutarate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

End products of AST/SGOT

A

Glutamic acid (glutamate)

Oxaloacetic acid (oxaloacetate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Color developer for AST/SGOT

A

2,4 DNPH
(2,4-Dinitrophenylhydrazine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Color intensifier for AST/SGOT

A

0.4 N NaOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Colorimetric method
for aminotransferase

A

Reitman and Frankel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Major source of AST/SGOT

A

Heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

T/F

AST/SGOT is widely distributed

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Tissue sources of AST/SGOT with increased activities

A
  • Cardiac tissue
  • Liver
  • Skeletal muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

AST/SGOT is increased in these conditions

A
  • AMI
  • Hepatocellular disorder: chronic liver disorder with progressive damage
  • Skeletal muscle disorder: muscular dystrophy (Duchenne)
  • Trichinosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Enzyme increased in
chronic liver disorder with progressive damage

A

AST/SGOT
(a hepatocellular disorder)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Enzyme increased in muscular dystrophy (Duchenne)

A

AST/SGOT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Enzyme increased in Trichinosis

A

AST/SGOT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Isoenzymes of AST/SGOT

A

Cytoplasmic AST
Mitochondrial AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

most abundant AST isoenzyme in normal serum

A

Cytoplasmic AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

AST isoenzyme present in mitochondrial membrane

A

Mitochondrial AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

AST isoenzyme that is increased in cell necrosis

A

Mitochondrial AST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Assay for AST/SGOT

A

KARMEN METHOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

2°/indicator enzyme used in Karmen method for AST

A

Malate Dehydrogenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Coenzyme used in Karmen method for AST

A

Pyridoxal phosphate/Vit B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Monitored in Karmen method for AST and the wavelength used

A

decrease in absorbance at 340 nm
(measures oxidized NAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Variables in Karmen method? What will be the effect?

A

Hemolysis (False ↑) – very sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Reference range for AST/SGOT using Karmen method

A

5 – 30 U/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

T/F

Product formed by the 1° enzyme (AST) will become the substrate for the 2° enzyme (MD)

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

In Karmen method, what is the substrate used by MD which is also the product formed by the primary enzyme AST?

A

oxaloacetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

In Karmen method, what are the products formed acted upon by MD?

A

malate + NAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Transfer of an amino group between alanine
and α-ketoglutarate

A

Alanine Aminotransferase (ALT)/
Serum glutamic-pyruvic transaminase (SGPT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

More liver specific than AST

A

Alanine Aminotransferase (ALT)/
Serum glutamic-pyruvic
transaminase (SGPT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Major organ affected by ALT/SGPT

A

LIVER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Substrates used by ALT/SGPT

A

Alanine

a-ketoglutaric acid (a-ketoglutarate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

End products of ALT/SGPT

A

Glutamic acid (glutamate)

Pyruvic acid (pyruvate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Color developer for ALT/SGPT

A

2,4 DNPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Color intensifier for ALT/SGPT

A

0.4 N NaOH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Major source of ALT/SGPT

A

LIVER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Minor sources of ALT/SGPT

A
  • Kidneys
  • Pancreas
  • RBC
  • Heart
  • Skeletal muscle
  • Lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

ALT/SGPT is increased in these conditions

A
  • Hepatocellular disorders
    (liver specific enzyme)
  • Acute liver inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Enzyme used to monitor hepatitis treatment
and drug therapy effects

A

ALT/SGPT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Enzyme used to screen post transfusion hepatitis

A

ALT/SGPT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Screens blood donors (not routine; only with jaundice)

A

ALT/SGPT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Sensitive test for
occupational toxic exposure

A

ALT/SGPT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Assay for ALT/SGPT

A

LACTATE DEHYDROGENASE (LD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

2°/indicator enzyme for ALT/SGPT assay

A

LACTATE DEHYDROGENASE (LD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Coenzyme used in LD for ALT

A

Pyridoxal phosphate/Vit B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Monitored in LD for ALT? What is the wavelength?

A

decrease in absorbance at 340 nm
(measures oxidized NAD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Reference range for ALT using LD assay

A

6 – 37 U/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

In LD assay, what is the substrate used by LD which is also the product formed by the primary enzyme ALT?

A

pyruvate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

In LD assay for ALT, what are the products formed by LD?

A

lactate + NAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

aka De Ritis Ratio

A

AST/ALT Ratio
SGOT/SGPT Ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Used to differentiate the cause of hepatic disorder

A

De Ritis Ratio (AST/ALT Ratio)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

De Ritis Ratio (AST/ALT Ratio):

> 1

A

nonviral origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

De Ritis Ratio (AST/ALT Ratio):

<1

A

viral origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

what is the cause of hepatic disorder when the AST is higher than ALT?

A

non-viral
>1 (high AST: low ALT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

what is the cause of hepatic disorder when the ALT is higher than AST?

A

viral
<1 (low AST: high ALT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

T/F

In De Ritis Ratio, a ratio of exactly 1 is possible.

A

FALSE!

Ratio of 1 is not possible because AST has MANY tissue sources

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

Catalyze transfer of γ-glutamyl residue from γ-glutamyl peptides to amino acids, H20, etc.

A

Gamma-Glutamyltransferase
(GGT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Common donor (biologic system) in GGT

A

glutathione

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

Substrates used in GGT

A

Glutathione + AA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

Products formed when GGT is used as an enzyme

A

glutamyl-peptide +
L-cysteinylglycine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

Source of GGT

A

Canaliculi of hepatic cells, specifically in the
epithelial lining of biliary ductulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

GGT is used to diagnose these conditions

A

Hepatobiliary disorders (obstructive jaundice)

Chronic alcoholism (ethanol intoxication)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Marker for occult alcoholism

A

GGT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Most sensitive marker for acute alcoholic hepatitis

A

GGT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

Assay for GGT

A

SZAZ ASSAY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

measures the absorbance of p-nitroaniline at 405-420 nm

A

SZAZ ASSAY for GGT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

Wavelength used in Szaz assay to measure p-nitroaniline

A

405-420 nm (visible light region)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

T/F
Wavelength requirement may be a clue to the detected product

A

T

400-700 nm – visible light region

Nonvisible regions:
<400 – UV region
>700 – IR region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

substrates used in Szaz assay using GGT

A

y-glutamyl-p-nitroanilide +
glycylglycine

145
Q

products formed in Szaz assay using GGT

A

y-glutamyl-glycylglycine +
p-Nitroaniline

146
Q

Catalyze hydrolysis of phosphomonoesters
at an acid pH (5.0)

A

Acid Phosphatase (ACP)/
Acid Orthophosphoric Monoester
Phosphohydrolase

147
Q

Liberate inorganic PO4 from an organic PO4
ester with alcohol production at an acid pH

A

Acid Phosphatase (ACP)/
Acid Orthophosphoric Monoester
Phosphohydrolase

148
Q

pH requirement in ACP

A

5.0

149
Q

NOT prostate specific

A

Acid Phosphatase (ACP)/
Acid Orthophosphoric Monoester
Phosphohydrolase

150
Q

Incorporated in the prostatic fluid secreted by
the prostate gland (normally present in
seminal fluid)

A

Acid Phosphatase (ACP)/
Acid Orthophosphoric Monoester
Phosphohydrolase

151
Q

Substrates used in ACP

A

phosphomonoester + H2O

152
Q

Products formed by ACP

A

alc + phosphate ion

153
Q

Sources of ACP

A
  • Prostate (male)
  • RBCs
  • Platelets
  • Bone (osteoclast – for bone resorption)
154
Q

Detects metastatic prostatic cancer

A

ACP

155
Q

Significant in forensic rape investigation

A

ACP

156
Q

Sample used in forensic rape investigation using ACP

A

vaginal washings from rape victim

157
Q

Detectability of ACP in forensic rape investigation

A

4 days or less

(Options if >4 days: vaginal laceration)

158
Q

Added to differentiate
prostatic form (specific) from nonspecific
form like RBC ACP

A

Inhibitor

159
Q

Inhibitors used for ACP

A

L-tartrate ions
Formaldehyde,
Cupric ions

160
Q

L-tartrate ions inhibits these ACP isoenzymes

A

prostatic ACP
lysosomal ACP

161
Q

Formaldehyde,
Cupric ions inhibits this ACP isoenzyme

A

RBC ACP

162
Q

Reference range for Prostatic ACP

A

0-3.5 ng/ml

163
Q

In Shinowara method, what is the substrate used and the products formed?

A

substrate: p-nitrophenyl-phosphate (PNPP) - COLORLESS

products: p-nitrophenol -YELLOW
phosphate ion

164
Q

general methods for ACP

A

Quantitative end point
Continuous monitoring

165
Q

Substrate used is Thymolphthalein monophosphate (most commonly used; sensitive and specific)

A

Quantitative end point

166
Q

Substrate used is a-naphthyl phosphate for ACP

A

Continuous monitoring

167
Q

Catalyze hydrolysis of phosphomonoesters at an Alk pH (9-10) (cleaves monoester bonds present in substrates)

A

Alkaline Phosphatase (ALP)/
Alkaline Orthophosphoric Monoester Phosphohydrolase

168
Q

Liberate inorganic PO4 from an organic PO4
ester with alcohol production at an Alk pH

A

Alkaline Phosphatase (ALP)/
Alkaline Orthophosphoric
Monoester Phosphohydrolase

169
Q

pH required in ALP

A

9-10

170
Q

Hydrolase enzyme that requires an activator

A

ALP

171
Q

Activator used in ALP

A

Mg2+

172
Q

T/F

ALP is liver specific

A

F

173
Q

Predominant ALP isoenzyme in normal serum

A

Liver ALP
Bone ALP

174
Q

Sources of ALP

A
  • Liver
  • Bone (osteoblast)
  • Placenta
  • Intestine
  • Renal tissues (not measured)
175
Q

Enzyme significantly ↑ in Paget’s disease/Osteitis deformans

A

ALP

176
Q

ALP is significantly increased in this condition

A

Paget’s disease/
Osteitis deformans

177
Q

Important for evaluation of hepatobiliary (obstructive types) and bone disorders

A

ALP

178
Q

ALP Isoenzymes

A
  1. Liver ALP
  2. Bone ALP
  3. Placental ALP
  4. Intestinal ALP
179
Q

Assay for ALP

A

Bowers and McComb

180
Q

Principle: molar absorptivity of p-Nitrophenol, Absorbance is measured at 405 nm (colorimetric measurement of yellow-colored p-Nitrophenol), pH 10.2

A

Bowers and McComb for ALP

181
Q

optimal pH used in Bowers and McComb

A

10.2

182
Q

In Bowers and McComb, absorbance is measured at this wavelength

A

405 nm

183
Q

colorimetric measurement of yellow-colored p-Nitrophenol as product of ALP

A

Bowers and McComb

184
Q

ALP Reference range in ADULTS

A

30 – 90 U/L

185
Q

ALP Reference range in 0-3 months

A

70 – 220 U/L

186
Q

ALP Reference range in 3-10 years

A

50 – 260 U/L

187
Q

ALP Reference range in 10 yr - puberty

A

60 – 295 U/L
highest due to active bone development; involves osteoblast resulting to release of ALP in serum)

188
Q

Fastest ALP isoenzyme

A

Liver ALP

189
Q

2 fractions of Liver ALP

A

Major liver band
Fast liver (a1) band

190
Q

responsible for predominant liver ALP level in normal serum

A

Major liver band

191
Q

responsible for fast-migrating liver ALP in electrophoresis

A

Fast liver (a1) band

192
Q

Liver ALP is increased PATHOLOGICALLY in

A

Liver diseases

193
Q

Most anodal (fastest) ALP isoenzyme

A

Liver ALP

194
Q

3rd most heat stable ALP isoenzyme

A

Liver ALP

195
Q

ALP residual activity after heating:
decreased to >20%

A

Liver ALP

196
Q

ALP isoenzyme inhibited by Levamisole

A

Liver ALP
Bone ALP

197
Q

Heat labile ALP isoenzyme (If the temp is ↑, activity is markedly ↓)

A

Bone ALP

198
Q

Bone ALP is increased PHYSIOLOGICALLY in

A

Bone growth

199
Q

Bone ALP is increased PATHOLOGICALLY in

A
  • Bone disease
  • Healing of bone fractures
200
Q

2nd most anodal ALP isoenzyme

A

Bone ALP

201
Q

Least heat stable ALP isoenzyme

A

Bone ALP

202
Q

ALP residual activity after heating:
decreased to <20%

A

Bone ALP

203
Q

ALP isoenzyme inhibited by 3M urea

A

Bone ALP

204
Q

Most heat stable ALP isoenzyme (withstand heating at 65ºC for 30 minutes)

A

Placental ALP

205
Q

Placental ALP can withstand this temperature for how many minutes

A

65ºC for 30 minutes

206
Q

Placental ALP is increased PHYSIOLOGICALLY in

A

Pregnancy (16th & 20th week of gestation)

207
Q

Placental ALP is increased PATHOLOGICALLY in

A

Malignancy/cancer
(carcinoplacental ALP)

208
Q

3rd most anodal ALP isoenzyme

A

Placental ALP

209
Q

Inhibited by Phenylalanine

A

Placental ALP
Intestinal ALP
Regan ALP
Nagao ALP

210
Q

Slowest moving ALP fraction

A

Intestinal ALP

211
Q

Intestinal ALP is increased PHYSIOLOGICALLY in

A
  • Blood group B and O
  • Fatty meal consumption
212
Q

Intestinal ALP is increased PATHOLOGICALLY in

A

GIT disorders

213
Q

Least anodal ALP isoenzyme

A

Intestinal ALP

214
Q

2nd most heat stable ALP isoenzyme

A

Intestinal ALP

215
Q

Total ALP elevations by Liver or Bone ALP are
differentiated by heating of serum at 56°C for 10 mins.
(focuses on liver and bone due to predominance)

A

HEAT STABILITY

216
Q

Adding of chemical reagent to the
sample to inhibit the activity of certain
isoenzyme

A

CHEMICAL INHIBITION

217
Q

CARCINOPLACENTAL ALP

A

REGAN ALP
NAGAO ALP

218
Q

Most heat stable ALP

A

REGAN ALP

219
Q

Bone ALP co-migrator

A

REGAN ALP
(2nd most anodal)

220
Q

Regan ALP is associated with these conditions

A

Lung, breast, gynecological cancers

221
Q

Nagao ALP is associated with these conditions

A

Adenocarcinoma of the pancreas and bile duct, pleural cancer

222
Q

Carcinoplacental ALP inhibited by Phenylalanine only

A

REGAN ALP

223
Q

Carcinoplacental ALP inhibited by both Phenylalanine and L-leucine

A

NAGAO ALP

224
Q

CARDIAC ENZYMES (MI PROFILE)

A

CK/CPK
LDH
AST

225
Q

Involved in the storage of high-energy
creatine phosphate in muscle cells

A

Creatine Kinase (CK)/
Creatine Phosphokinase
(CPK)

226
Q

transferase enzyme that catalyzes
the transfer of PO4 group betw. substrates

A

Kinase
(CPK – inappropriate term)

227
Q

high energy
reservoir in muscle cells; utilized by muscle
cells to form waste product - creatinine

A

Creatine phosphate

228
Q

originates in the liver from the amino acid arginine, glycine and methionine

A

Creatine

229
Q

amino acids where creatine originates

A

methionine
arginine
glycine

230
Q

formed from muscle metabolism; excreted in the nephrons of the kidney at a constant rate

A

Creatinine

231
Q

T/F
From the liver, creatine is transferred to the
muscles. In the muscles, creatine is converted
to creatine phosphate through the action of
the enzyme CK

A

T

232
Q

substrates used in CK

A

creatine + ATP

233
Q

products formed in CK

A

creatine phosphate + ADP

234
Q

T/F

CK is widely distributed

A

T

235
Q

CK has inc. activities in these tissues

A
  • skeletal muscle
  • heart
  • brain
236
Q

First cardiac enzyme to elevate after AMI

A

CK2 (CK-MB)
(>6% of total CK)

237
Q

Percentage of CK-MM

A

94-98%

238
Q

Percentage of CK-MB

A

2-6%

239
Q

Percentage of CK-BB

A

<1%

240
Q

Reference range of Total CK in MALE

A

15-160 U/L
(higher than female due to inc. activity & muscle mass)

241
Q

Reference range of Total CK in FEMALE

A

15-130 U/L

242
Q

Reference range of CK-MB

A

<6% of total CK

243
Q

Dimeric enzyme

A

CK
M - muscle, B - brain

244
Q

CK isoenzymes

A

CK 1 (CK-BB)
CK 2 (CK-MB)
CK 3 (CK-MM)
Macro-CK
CK-Mi

245
Q

CK isoenzyme that migrate fastest toward anode (most anodal)

A

CK1
CK-BB
Brain type

246
Q

CK isoenzyme: 2nd fastest to migrate toward anode

A

CK2
CK-MB
Hybrid type

247
Q

CK isoenzyme that migrate slowest toward anode (least anodal)

A

CK3
CK-MM
Muscle type

248
Q

CK1 (CK-BB) - Brain type has inc. concentration in these sites

A

CNS
GI tract
Uterus (pregnancy)

249
Q

Large CK molecule – cannot pass BBB

A

CK1
CK-BB
Brain type

250
Q

CK isoenzyme ↑ in heart tissue
(cardiac muscle specific)

A

CK2
CK-MB
Hybrid type

251
Q

↑ CK-MB denotes?

A

AMI

252
Q

Major isoenzyme in striated muscles and normal serum

A

CK3
CK-MM
Muscle type

253
Q

Macro-CK composition

A

CK-BB + antibodies (IgG/IgA)

CK-MM + lipoproteins

254
Q

Migrate midway betw. CK-MM and CK-MB

A

Macro-CK

255
Q

Migrates cathodal to CK-MM

A

Mitochondrial CK (CK-Mi)

256
Q

CK isoenzyme located in mitochondrial membrane; used to diagnose cell necrosis/severe damage

A

Mitochondrial CK (CK-Mi)

257
Q

Assay for CK

A

TANZER-GILVARG (FORWARD)
OLIVER-ROSALKI (REVERSE)

258
Q

Measured in TANZER-GILVARG (FORWARD)

A

↓ in absorbance at 340 nm

259
Q

Optimum pH in TANZER-GILVARG (FORWARD

A

9.0

260
Q

Measured in OLIVER-ROSALKI (REVERSE)

A

↑ in absorbance at 340 nm

261
Q

Optimum pH in OLIVER-ROSALKI (REVERSE)

A

6.8

262
Q

SOURCES OF ERROR for CK measurement

A

Hemolysis (false inc.)
Physical activity and IM injections (false inc.)
Photosensitive (false dec.)
Immobilized/bedridden (false dec.)

263
Q

Abundant enzyme inside the RBC that mimics the activity of CK causing hemolysis as a source of error

A

Adenylate kinase

264
Q

Catalyzes interconversion of lactic and pyruvic acids

A

Lactate Dehydrogenase (LDH)

265
Q

T/F
LDH is tissue specific

A

False
*Widely distributed

266
Q

This may affect LDH activity

A

Storage

↓: frozen/low temp.
Maintained: RT for 2 days

267
Q

Substrate for LD

A

Lactate + NAD

268
Q

Products of LD

A

Pyruvate + NADH + H+

269
Q

Inc. activities of LD are found in:

A
  • Heart
  • Liver
  • Skeletal muscle
  • RBC
270
Q

Late cardiac marker (not practical for AMI dx)

A

LDH

271
Q

SOLE PURPOSE: Monitor px response to therapy for cardiac diseases (i.e. AMI)

A

LDH

272
Q

LDH reference range

A

100-225 U/L

273
Q

Tetramer enzyme

A

LDH
(4 subunits/monomers of two active sub-unit forms [H & M]) H - heart, M - muscle

274
Q

Tissue source of LDH 1

A

Heart,
RBC

275
Q

Tissue source of LDH 2

A

Heart,
RBC

276
Q

Tissue source of LDH 3

A

Lung,
Spleen,
Pancreas

277
Q

Tissue source of LDH 4

A

Liver

278
Q

Tissue source of LDH 5

A

Skeletal muscle,
Liver

279
Q

Disorder associated with LDH 1

A

AMI,
Hemolytic anemia

280
Q

Disorder associated with LDH 2

A

Renal Infarction,
Megaloblastic anemia

281
Q

Disorder associated with LDH 3

A

Pulmonary embolism

282
Q

Disorder associated with LDH 4

A

Hepatic injury

283
Q

Disorder associated with LDH 5

A

Muscle dystrophy
Hepatic disorders

284
Q

percentage of LDH 1 in total LDH

A

20-30%

285
Q

percentage of LDH 2 in total LDH

A

30-40%

286
Q

percentage of LDH 3 in total LDH

A

20-25%

287
Q

percentage of LDH 4 in total LDH

A

7-15%

288
Q

percentage of LDH 5 in total LDH

A

5-15%

289
Q

LDH isoenzyme NOT normally seen in healthy people

A

LDH 6 / Alcohol dehydrogenase

290
Q

LDH 6 / Alcohol dehydrogenase is present in these conditions

A

Drug hepatotoxicity
Obstructive jaundice
Atherosclerotic failure

291
Q

has high affinity to α-hydroxybutyrate

A

LDH 1

292
Q

LDH Normal Electrophoretic migration pattern

A

LDH 1>2>3>4>5

293
Q

LDH Relative conc. in normal serum

A

LDH 2>1>3>4>5

294
Q

LDH pattern in AMI/IV hemolysis

A

LDH 1>2>3>4>5
(FLIPPED PATTERN)

295
Q

Used to differentiate AMI from IV hemolysis with flipped pattern

A

LDH 1
CK-MB

296
Q

Differentiate AMI from IV hemolysis

A

AMI: high LDH1, high CK-MB

IV hemolysis: high LDH1, normal CK-MB

297
Q

Assays for LDH

A

WACKER METHOD (FORWARD)
WROBLEUSKI LA DUE (REVERSE)
α-hydroxybutyrate dehydrogenase (α-HBD)

298
Q

Assay: Lactate —> Pyruvate

A

WACKER METHOD (FORWARD)

299
Q

Assay: Pyruvate —> Lactate

A

WROBLEUSKI LA DUE (REVERSE)

300
Q

Measured in WACKER METHOD (FORWARD)

A

↑ in absorbance at 340 nm

301
Q

Optimal pH in WACKER METHOD (FORWARD)

A

8.3 – 8.9

302
Q

Commonly used LDH measurement due to:
o Production of positive rate
o Not affected by product inhibition

A

WACKER METHOD (FORWARD)

303
Q

Measured in WROBLEUSKI LA DUE (REVERSE)

A

↓ in absorbance at 340 nm

304
Q

Optimal pH in WROBLEUSKI LA DUE (REVERSE)

A

7.1 – 7.4

305
Q

3x faster but more susceptible to substrate exhaustion

A

WROBLEUSKI LA DUE (REVERSE) for LDH

306
Q

Has greater affinity of H subunit

A

α-hydroxybutyrate dehydrogenase (α-HBD)

307
Q

α-hydroxybutyrate dehydrogenase (α-HBD) represent this LDH isoenzyme

A

LDH 1
(only isoenzyme with complete 4 subunits)

308
Q

CK-MB (>6%) in AMI

Appearance (rise):
Peak:
Normalize:

A

Appearance (rise): 4-8 hours (EARLIEST)
Peak: 12-24 hours
Normalize: 3 days

309
Q

AST in AMI

Appearance (rise):
Peak:
Normalize:

A

Appearance (rise): 6-8 hours
Peak: 24 hours
Normalize: 5 days

310
Q

LDH in AMI

Appearance (rise):
Peak:
Normalize:

A

Appearance (rise): 10-24 hours (late to rise)
Peak: 48-72 hours
Normalize: 10 days (longest to persist)
Normalize after 10 days

311
Q

Secreted by the acinar cells of the pancreas, useful in the digestion process

A

PANCREATIC ENZYMES

312
Q

Catalyzes breakdown of starch and glycogen via α, 1-6 branching linkages

A

Amylase (AMS)

313
Q

First enzyme to elevate in acute pancreatitis but nonspecific

A

Amylase (AMS)

314
Q

Smallest enzyme in terms of molecular weight

A

Amylase (AMS)

315
Q

Reaction eq. of AMS

A

CHO –(AMS)–> Maltodextrins

316
Q

Major source of AMS

A
  • Pancreas (acinar cells)
  • Salivary gland
317
Q

Minor source of AMS

A
  • Fallopian tube
  • Adipose tissues
  • Small intestine
  • Skeletal muscle
318
Q

AMS is inc. in these conditions

A
  • Acute pancreatitis
  • Parotitis
  • Renal failure
  • Macroamylasemia
319
Q

Earliest nonspecific marker of acute pancreatitis

A

Amylase (AMS)

320
Q

Inflammation of carotid gland (viral infections), AMS hypersecretion in serum

A

Parotitis

321
Q

T/F

AMS is normally filtered in glomerulus due to its low mol. weight; normally present in urine. During renal failure (altered kidney filtration) → AMS cannot pass through → reabsorbed → returned back to serum.

A

T

322
Q

AMS + Ab/Ig; not filtered by glomerulus; reabsorbed

A

Macroamylasemia

323
Q

aka Salivary Amylase

A

Ptyalin

324
Q

fast moving; more anodal AMS isoenzyme (lower conc. in serum)

A

Ptyalin (salivary amylase)

325
Q

slow moving AMS isoenzyme (highest conc. in serum)

A

Amylopsin (Pancreatic amylase)

326
Q

aka Pancreatic amylase

A

amylopsin

327
Q

AMYLASE METHODOLOGIES

A

AMYLOCLASTIC
SACCHAROGENIC
CHROMOGENIC
CONTINUOUS MONITORING

328
Q

Measures disappearance of starch substrate

A

AMYLOCLASTIC

329
Q

Indicator used in AMYLOCLASTIC method for AMS

A

Iodine (only react with polysaccharide)

330
Q

Color of Starch-Iodine complex

A

dark-blue

331
Q

Color of Glycogen-Iodine complex

A

mahogany-brown (a substitute for starch)

332
Q

T/F

Decrease in color intensity is due to the conversion by AMS of polysaccharide substrates to simpler form (Thus, absorbance measured is also decreased)

A

T
(amyloclastic method)

333
Q

T/F

In AMYLOCLASTIC method for amylase,

AMS activity = Absorbance

A

F

AMS activity ∝ Absorbance

334
Q

Measured in this method is the product appearance (liberated reducing sugar)

A

SACCHAROGENIC
Starch → reducing sugars

335
Q

T/F

In SACCHAROGENIC method for amylase,

AMS = Reducing sugar formed

A

T

336
Q

Measures the increasing color from production of product acted by AMYLASE

A

CHROMOGENIC
(uses chromogenic dye fragment)

337
Q

T/F

In CHROMOGENIC method for amylase,

AMS activity = soluble starch-dye fragment formed

A

T

338
Q

Coupling of several enzyme to monitor AMS activity

A

CONTINUOUS
MONITORING

339
Q

Measured in CONTINUOUS MONITORING for amylase

A

↑ in absorbance at 340 nm

340
Q

Several enzymes used in cont. monitoring for ams

A

AMS
a-glucosidase
HK
G6PD

341
Q

Target of LPS

A

ester bonds (present in lipids/fats)

342
Q

Hydrolyzes ester linkages of fats to produce alcohols and fatty acids

A

Lipase (LPS)

343
Q

Hydrolysis of dietary TAG in the intestine to 2-monoglyceride and fatty acids (enhances fat absorption)

A

Lipase (LPS)

344
Q

Larger molecule of pancreatic enzyme

A

Lipase

345
Q

Pancreatic enzyme that remains longer in circulation

A

Lipase

346
Q

Reaction eq. of LPS

A

Triacylglycerol + 2H2O —LPS—> 2-monoglyceride + 2 FA

347
Q

Only source of LPS

A

Pancreas (acinar cells)

348
Q

Early and specific marker of acute pancreatitis

A

Lipase
(but not as fast as AMS)

349
Q

Assays for lipase

A

CHERRY CRANDALL
TIETZ
Turbidimetric methods

350
Q

Substrate in Cherry Crandall

A

50% olive oil (triolein – a purer form of fat reagent)

351
Q

Substrate in Tietz

A

50% olive oil (triolein – a purer form of fat reagent)

352
Q

Titrating agent in Cherry Crandall

A

0.4N NaOH (fatty acid titration is done)

353
Q

Titrating agent in Tietz

A

0.4N NaOH (fatty acid titration is done)

354
Q

Indicator and end color in Cherry Crandall

A

Phenolphthalein
Pink

355
Q

Indicator and end color in Tietz

A

Thymolphthalein + Veronal
Blue

356
Q

End point of both Cherry Crandall and Tietz

A

Fatty Acid (Oleic Acid)

357
Q

Estimation of liberated fatty acids by measuring the amount of light blocked by the insoluble particles in the sample

A

Turbidimetric methods for Lipase

358
Q

Reagent used in turbidimetric methods for LPS

A

TAG (hydrophobic, nonpolar, insoluble – turbid soln)

359
Q

T/F

When LPS act
on TAG, it will be converted to a more polar, soluble – clear soln)
**Measured absorbance is DECREASED (inversely proportional)

A

T

360
Q

AMYLASE in acute pancreatitis

Rise:
Peak:
Persists:

A

Rise: 2-12 hours (earliest)
Peak: After 24 hours
Persists: 3-5 days

361
Q

LIPASE in acute pancreatitis

Rise:
Peak:
Persists:

A

Rise: 6 hours
Peak: After 24 hours
Persists: 7 days (longest to persist)